Results 131 to 140 of about 163,074 (266)

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Congenital factor VII deficiency: When to suspect?

Pediatric Hematology Oncology Journal, 2016
Ankit Ranjan, Sushma Malik, Poonam Wade, Purvi Kadakia   +3 more
doaj   +1 more source

Factor VII deficiency is more prevalent than previously reported. [PDF]

Res Pract Thromb Haemost
Löwing Svensson L, Aardal E, Holmström M.   +2 more
europepmc   +1 more source

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova, Jan Smeitink, Herma Renkema, Rosabeth White, Frankie Barton, Rachel Lyon, Jane Newman, Aye Moe, Yi Shiau Ng, Grainne Siobhan Gorman   +9 more
wiley   +1 more source

Active factor VII levels in patients with cirrhosis

The Turkish Journal of Gastroenterology, 2001
Fahri IŞITAN, Levent ÜNDAR, Cemal ERTUĞRUL, İnci SÜLEYMANLAR   +3 more
doaj  

Congenital factor VII deficiency as a cause of postpartum hemorrhage: A case report. [PDF]

Case Rep Womens Health
Hernández Zanata JR, Gámez Garza MA, Macias Paz IU, Ledezma Flores E, Del Ángel De León RA, Guerra Cárdenas JE.   +5 more
europepmc   +1 more source

Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Hannah Kopinsky, Melissa Lopez, Janet Miller, Millenia Jimenez, Eric M. Liotta, Igor J. Koralnik   +5 more
wiley   +1 more source

The effects of recombinant human activated factor VII and tranexamic acid on traumatic bleeding and mortality in mice. [PDF]

Res Pract Thromb Haemost
Chumappumkal Joseph B, De Pablo-Moreno JA, Falah N, Wentzel A, Lora Cacho M, Frias-Anaya E, Lopez-Ramirez MA, von Drygalski A.   +7 more
europepmc   +1 more source

Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency. [PDF]

Blood Adv, 2022
Seanoon K, Payongsri P, Vivithanaporn P, Sirachainan N, Chuansumrit A, Hongeng S, Tanratana P.   +6 more
europepmc   +1 more source

Baseline Neuroinflammation Stratifies TSPO‐PET Response to Disease‐Modifying Therapy in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch, Markus Matilainen, Giulia N. Baldrighi, Marjo Nylund, Maija Saraste, Laura Airas   +5 more
wiley   +1 more source